| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/21/2011 | US7964186 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 06/21/2011 | US7964185 Apicomplex vaccine strains of a family of Sarcocystidae |
| 06/21/2011 | US7963997 Device for regeneration of articular cartilage and other tissue |
| 06/21/2011 | CA2523098C Skin collagen production promoter |
| 06/21/2011 | CA2439857C Caloporoside derivatives, process for their preparation and their use |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2340328C Stable hypoxia inducible factor-1 alpha and method of use |
| 06/16/2011 | WO2011072119A2 Stem-cell material and method of use |
| 06/16/2011 | WO2011072012A2 Improved methods and compositions for vein harvest and autografting |
| 06/16/2011 | WO2011071453A1 Glycosaminoglycan mixtures |
| 06/16/2011 | WO2011071370A1 Probiotic lactic acid bacteria |
| 06/16/2011 | WO2011071134A1 Prophylactic composition for influenza infection |
| 06/16/2011 | WO2011071118A1 Agent for promoting differentiation of pluripotent stem cells into cardiac muscle cells which includes nitrovin |
| 06/16/2011 | WO2011070974A1 Cell preparation for treating prostatic cancer comprising adipose tissue-derived mesenchymal stem cells |
| 06/16/2011 | WO2011070305A1 Pharmaceutical composition for the treatment of orthopedic pathologies |
| 06/16/2011 | WO2011070168A1 Pharmaceutical composition for treating cutaneous burns |
| 06/16/2011 | WO2011069987A1 Infant formula with probiotics and milk fat globule membrane components |
| 06/16/2011 | WO2011069860A1 Novel use for the treatment of metabolic endotoxemia |
| 06/16/2011 | WO2011069527A1 Treatment scheme for idd and other automimmune diseases |
| 06/16/2011 | WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/16/2011 | WO2011039631A3 Expression of meningococcal fhbp polypeptides |
| 06/16/2011 | WO2011031476A3 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
| 06/16/2011 | WO2011020095A3 Compositions and methods of treating inflammation |
| 06/16/2011 | WO2011019822A3 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products |
| 06/16/2011 | WO2011017143A3 Compositions and methods of preparing alloreactive cytotoxic t cells |
| 06/16/2011 | WO2011011388A3 Neuregulin induced regeneraton of heart muscle muscle |
| 06/16/2011 | WO2010136900A3 Methods of using krill oil to treat risk factors for metabolic disorders and obesity |
| 06/16/2011 | US20110145938 Method for generating monoclonal antibodies that recognize progenitor cells |
| 06/16/2011 | US20110144004 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 06/16/2011 | US20110143438 Process for Decellularizing Soft-Tissue Engineered Medical Implants, and Decellularized Soft-Tissue Medical Implants Produced |
| 06/16/2011 | US20110142956 Use of a pde 5 inhibitor for treating and preventing hypopigmentary disorders |
| 06/16/2011 | US20110142955 Agent for ameliorating stress-induced immune function modulation |
| 06/16/2011 | US20110142954 Topical treatment and manufacturing method |
| 06/16/2011 | US20110142935 Cardiac differentiation of human pluripotent stem cells under defined conditions using matrix overlay methods |
| 06/16/2011 | US20110142924 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein |
| 06/16/2011 | US20110142911 HIV epitopes and pharmaceutical composition containing same |
| 06/16/2011 | US20110142905 Coated tablets with remaining degradation surface over the time |
| 06/16/2011 | US20110142902 Hypoxia Inducing Factor (HIF) Stabilising Glasses |
| 06/16/2011 | US20110142885 Spray-dried human plasma |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142878 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 06/16/2011 | US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142864 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142842 Polypeptides |
| 06/16/2011 | US20110142814 Methods for Using Protein Kinase C-Theta Inhibitors in Adoptive Immunotherapy |
| 06/16/2011 | US20110142813 Use Of Anti-Cancer Cell Composition For Treatment Of Head And Neck Cancer, Which Is Intended To Be Administered To Nutrient Artery Of Tumor |
| 06/16/2011 | US20110142812 Suppressive macrophages, c-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura |
| 06/16/2011 | US20110142811 Measles virus for the elimination of unwanted cell populations |
| 06/16/2011 | US20110142810 Cell preparation for bone tissue regeneration |
| 06/16/2011 | US20110142809 Method for separating highly active stem cells from human stem cells and highly active stem cells separated thereby |
| 06/16/2011 | US20110142808 Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
| 06/16/2011 | US20110142807 Mesenchymal Stem Cells and Uses Therefor |
| 06/16/2011 | US20110142806 Electroactive Scaffold |
| 06/16/2011 | US20110142805 Method of renal repair and regeneration and the treatment of diabetic nephropathy |
| 06/16/2011 | US20110142804 Nanofiber scaffold |
| 06/16/2011 | US20110142803 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia |
| 06/16/2011 | US20110142793 Composition for treating articular cartilage defect, and method of manufacture thereof |
| 06/16/2011 | US20110142773 Composition and periodical delivery system for cellular rejuvenation |
| 06/16/2011 | CA2836117A1 Oncolytic rhabdovirus |
| 06/16/2011 | CA2784928A1 Pharmaceutical composition for treating cutaneous burns |
| 06/16/2011 | CA2783768A1 Infant formula with probiotics and milk fat globule membrane components |
| 06/16/2011 | CA2783236A1 Improved methods and compositions for vein harvest and autografting |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333093A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2333049A1 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 06/15/2011 | EP2333048A1 PDGF for use in inducing proliferation of a neural progenitor cell that differentiates into neurons and oligodendrocytes by not astrocytes |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332573A1 Chimeric alphavirus replicon particles |
| 06/15/2011 | EP2332557A1 Probiotic lactic acid bacteria |
| 06/15/2011 | EP2332556A1 Use of yeasts for treating stomach or intestinal ulcers induced by gastrotoxic agents |
| 06/15/2011 | EP2332539A1 Pharmaceutical preparation, food or beverage having inhibitory activity on serotonin transporter |
| 06/15/2011 | EP2332424A1 Method for producing lipid |
| 06/15/2011 | EP2331675A1 Markers of induced pluripotent stem cells |
| 06/15/2011 | EP2331110A1 Compositions and methods for engineering probiotic yeast |
| 06/15/2011 | EP2331109A1 Methods and compositions for treatment of bone defects with placental cell populations |
| 06/15/2011 | EP1642981B1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |
| 06/15/2011 | EP1641475B1 Lipids from methanotrophic bacteria for cholesterol reduction |
| 06/15/2011 | EP1213971B1 Improving condition of elderly pets |
| 06/15/2011 | EP1131080B2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | CN201861992U Multiple coating mirco-capsulation lactic acid bacteria (MCM-LAB) structure |
| 06/15/2011 | CN1813881B Chinese medicine composition for treating asthma |
| 06/15/2011 | CN102099451A Krill oil process |
| 06/15/2011 | CN102099050A Orally administrable dosage forms comprising angiogenin and uses thereof |
| 06/15/2011 | CN102099045A Attenuated oncolytic paramyxoviruses encoding avian cytokines |
| 06/15/2011 | CN102099044A Use of probiotic bacteria for the treatment of hyperhomocysteinaemia |
| 06/15/2011 | CN102099043A Repair and/or reconstitution of invertebral discs |
| 06/15/2011 | CN102099033A Pharmaceutical composition for treatment of fibromyalgia |
| 06/15/2011 | CN102098929A Composition of soluble indigestible fibre and of eukaryotic organisms with a polysaccharide wall, used in the well-being field |
| 06/15/2011 | CN102093984A Hybrid enzyme P450sca2-BMR (Brown Mid Rib), and coding gene and application thereof |
| 06/15/2011 | CN102093440A Coproduction process of pig brain protein hydrolysate and monosialoganglioside |
| 06/15/2011 | CN102091324A Calcium for nourishing bones |
| 06/15/2011 | CN102091321A Medicament oral liquid for treating enteritis and diarrhea and preparation method thereof |
| 06/15/2011 | CN102091320A Toad peptide antibiotics for preparing medicine for treating liver cancer |
| 06/15/2011 | CN102091319A Toad peptide antibiotic for preparing medicaments for treating herpes zoster |
| 06/15/2011 | CN102091318A Toad peptide antibiotics separated from toad maggots and preparation method of antibacterial drugs thereof |
| 06/15/2011 | CN102091317A Qi-tonifying desensitizer and use thereof |
| 06/15/2011 | CN102091316A Traditional Chinese medicine for treating rheumatoid arthritis |